SKP
MRK icon

Sanborn Kilcollin Partners’s Merck MRK Stock Holding History

Sanborn Kilcollin Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$8.73M Sell
154,280
-80,373
-34% -$4.51M 6.1% 7
2014
Q2 		$13M Buy
234,653
+1,892
+0.8% +$103K 5.97% 7
2014
Q1 		$12.6M Buy
232,761
+11,119
+5% +$576K 6.36% 7
2013
Q4 		$10.6M Sell
221,642
-14,222
-6% -$650K 5.52% 8
2013
Q3 		$10.7M Buy
235,864
+19,408
+9% +$886K 5.65% 7
2013
Q2 		$9.59M Buy
+216,456
New +$9.67M 5.83% 7

Other funds holding MRK

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanborn Kilcollin Partners's MRK Position: Q3 2014 in Review

Sanborn Kilcollin Partners reduced its Merck (MRK) stake by 34% in Q3 2014, selling an estimated $4.51M and leaving 154,280 shares worth $8.73M. The position accounts for 6.1% of the portfolio, ranked #7.

Sanborn Kilcollin Partners first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. The position peaked at $13M in Q2 2014. 1,617 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • Sanborn Kilcollin Partners held 154,280 shares of Merck worth $8.73M as of Q3 2014.
  • Sanborn Kilcollin Partners sold 80,373 Merck shares in Q3 2014, an estimated $4.51M.
  • Merck made up 6.1% of Sanborn Kilcollin Partners's portfolio in Q3 2014, its #7 holding.
  • Sanborn Kilcollin Partners first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • Sanborn Kilcollin Partners's Merck position peaked at $13M in Q2 2014.
  • 1,617 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on Sanborn Kilcollin Partners's 13F filing for Q3 2014, filed 13 Nov 2014.